Is It Time To Reconsider Illumina (ILMN) After Mixed Multi Year Share Performance?

Endpoints NewsTreasury weighs screening investments in China biotech

BioPharma DivecAMPfield lands $180M to build gut disease drug

Endpoints NewsNovo Nordisk expands in China and Czech; Cellares boosts Series D by $50M

BioPharma DiveBiogen adds more immune drugs in $1B buyout of secretive startup Raythera

Promega BlogWhat Happens When You Delay an Ebola Vaccine Booster by 18 Months?

FierceBiotechcAMPfield harvests $180M series A to advance oral IBD drug licensed from Newsoara

Endpoints NewsIRA's Medicare out-of-pocket cap increased access to drugs, study finds

Endpoints NewsPrepping for peptides

BioPharma DivePfizer CFO to step down; Denali sells a regulatory fast-pass

Endpoints NewsPfizer CFO to depart; GSK wins approval for UTI drug

Endpoints NewsRA, Forbion and Sanofi Ventures appear to back new eye drug from Korea

Endpoints NewsNovocure’s electric fields therapy fails key glioblastoma study